Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling
Open Access
- 1 March 2003
- journal article
- Published by Elsevier
- Vol. 278 (10) , 7934-7941
- https://doi.org/10.1074/jbc.m209710200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Activation of the Bone Morphogenetic Protein Signaling Pathway Induces Inhibin B-Subunit mRNA and Secreted Inhibin B Levels in Cultured Human Granulosa-Luteal CellsJournal of Clinical Endocrinology & Metabolism, 2002
- Minireview: Inhibin Binding Protein (InhBP/p120), Betaglycan, and the Continuing Search for the Inhibin ReceptorMolecular Endocrinology, 2002
- Oocyte-expressed TGF-β superfamily members in female fertilityMolecular and Cellular Endocrinology, 2000
- Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cellsJournal of Cellular Physiology, 1999
- Identification of High Affinity Binding Sites for Inhibin on Ovine Pituitary Cells in CultureEndocrinology, 1999
- Mouse models of ovarian failureReviews of Reproduction, 1998
- Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145Journal of Endocrinology, 1997
- Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaPEndocrinology, 1996
- BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning.Genes & Development, 1995
- A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.Genes & Development, 1995